Harmony Biosciences Holdings, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 6.00M159.74M305.44M437.86M582.02M714.73M
Cost of Revenue 44.32M55.82M68.12M83.48M121.24M156.81M
Gross Profit 4.42M132.00M249.92M354.37M460.79M557.92M
Operating items
Research & Development 69.59M19.45M30.37M70.89M76.06M145.82M
Selling, General & Administrative 36.41M39.75M63.91M84.02M95.29M110.35M
Other Operating Expenses 44.32M55.82M68.12M79.28M97.40M110.92M
Operating Expenses 150.32M115.02M162.39M234.19M268.76M367.09M
Operating Income -145.90M16.99M87.53M120.19M192.03M190.83M
EBIT -145.90M16.99M87.53M120.19M192.03M190.83M
Non-operating items
Interest & Investment Income -6.07M-28.22M0.22M3.13M14.73M18.54M
Other Non Operating Income -22.64M-26.15M0.17M-9.77M-0.07M
Non Operating Income -3.07M0.02M0.17M0.16M-0.07M
Net income details
EBT -151.98M-36.94M37.43M104.69M173.40M191.80M
Tax Provisions -32.51M-6.42M6.49M-76.78M57.96M74.31M
Profit After Tax -151.98M-36.94M34.60M181.47M128.85M145.49M
Income from Continuing Operations -119.47M-30.53M30.94M181.47M115.43M117.49M
Consolidated Net Income -119.47M-30.53M30.94M181.47M115.43M117.49M
Income towards Parent Company -119.47M-30.53M30.94M181.47M115.43M117.49M
Preferred Dividend Payments 35.23M26.90M
Net Income towards Common Stockholders -187.21M-63.85M34.60M181.47M128.85M117.49M
Additional items
EPS (Basic) -0.00M-0.00M0.00M0.00M0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M0.00M0.00M0.00M0.00M
Shares Outstanding (Weighted Average) 62.98M56.89M58.47M59.32M56.77M57.03M
Shares Outstanding (Diluted Average) 7.78M25.77M59.21M61.10M60.37M57.87M
EBITDA -145.90M-36.94M34.60M181.32M129.01M145.56M
Tax Rate 21.39%17.37%17.33%33.43%38.74%